Marshall P Hyden II

MD
Advanced Heart Failure and Transplant Cardiology
Nebraska Medicine
Marshall Hyden

Brief Bio

Alliance Presentations

Rejection Surveillance

The Use of cf-DNA Testing for Rejection Surveillance in Heart Transplantation

Tuesday, April 23, 2024, at 2:00pm

Until the past few years, several routine surveillance biopsies were needed for all patients following heart transplantation.  Today, the use of cf-DNA testing has made frequent surveillance biopsies a thing of the past.  This presentation will discuss one center’s journey and their results to significantly lower the number of post-heart transplant biopsies during the first year.

Lifelong Networks

Our partners are the heart and soul of our organization. For more than 15 years, they have played a vital role providing quality education and programs to advance a shared mission.